Scott Kenneth Wooden

Title: Scott Kenneth Wooden: Innovator in the TNF Ligand Supergene Family

Introduction

Scott Kenneth Wooden is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of biotechnology, particularly through his work on the TNF ligand supergene family. With a total of three patents to his name, Wooden's innovations have the potential to impact various therapeutic applications.

Latest Patents

Wooden's latest patents include groundbreaking inventions related to a novel member of the TNF ligand supergene family. One of his patents, titled "Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators," provides a purified polynucleotide encoding a novel polypeptide, designated Fhm. This invention encompasses purified Fhm polypeptide molecules, antibodies that bind to Fhm, and methods for utilizing these molecules in various applications. Another patent with a similar title further emphasizes the significance of Fhm in the TNF gene superfamily, highlighting its potential in medical research and treatment.

Career Highlights

Scott Kenneth Wooden is currently associated with Amgen Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Amgen has allowed him to explore and develop his ideas in a collaborative environment, contributing to the advancement of biopharmaceuticals.

Collaborations

Wooden has collaborated with esteemed colleagues, including Hailing Hsu and William James Boyle. These partnerships have fostered a creative atmosphere that encourages the exchange of ideas and the development of innovative solutions in the field of biotechnology.

Conclusion

Scott Kenneth Wooden's contributions to the TNF ligand supergene family exemplify the impact of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.